International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of all issues and individual articles published by the Journal since 1997.

LEARN MORE

Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2019 - Volume 23, Number 2
View All Articles in Issue

Page(s): 147

Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: amlodipine, formulation, dihydropyridine calcium channel blocker, angina, high blood pressure, hypertension

Related Categories: FORMULATIONS, CARDIOLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2019 Pg. 147
Amlodipine 1-mg/mL in Oral Mix Suspension Allen Loyd V Jr	Mar/Apr 2021 Pg. 142
Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Allen Loyd V Jr	Jan/Feb 2021 Pg. 43
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 503
Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Allen Loyd V Jr	Nov/Dec 2019 Pg. 494
Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V	Nov/Dec 2019 Pg. 519-527
Amlodipine Besylate 1 mg/mL Veterinary Suspension Allen Loyd V Jr	Sep/Oct 2009 Pg. 429
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Mixon William, Helms Scott R	Sep/Oct 2008 Pg. 392-397
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 493
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Allen Loyd V Jr	Jul/Aug 2021 Pg. 327
Amlodipine 1-mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2006 Pg. 137
Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2018 Pg. 494
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 421
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai	Mar/Apr 2022 Pg. 155-162
Valsartan 4-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2021 Pg. 329
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Sep/Oct 2021 Pg. 412
Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Mar/Apr 2022 Pg. 140
Return to Top